Purchase Order 75N92020P00061

<p>The National Heart Lung and Blood Institute awarded a purchase order to Mission Bio, Inc. for $49,900 on January 24, 2020, for acquisition of a Missionbio single-cell multi-omics platform for the CLL Lab. Performance occurs in South San Francisco, California. The order is firm fixed price with an ultimate completion date of February 23, 2020.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Mission Bio, Inc. for $19,250 on July 1, 2019, for single-cell DNA sequencing library preparation materials. Work is performed in South San Francisco, California. The order is firm fixed price and carries an ultimate completion date of July 19, 2019.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Mission Bio, Inc. for hematology oligo panels on March 25, 2021, with a ceiling value of $56,400.00. Work is performed in South San Francisco, California. The order is firm fixed price with an ultimate completion date of April 25, 2021. The solicitation was posted March 18, 2021, with award issued the same day as the due date.</p>

Mission Bio, Inc. was awarded a $39,880 purchase order by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to deliver single-cell DNA protein reagent kits. The firm-fixed price order is for a one-year base period of performance beginning September 15, 2023 through September 14, 2024 in South San Francisco, California. The original solicitation sought single-cell DNA and protein reagent kits to support NHLBI's research efforts...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Mission Bio, Inc. for Tapestri Single-Cell Kits valued at $26,400 on September 18, 2018. Work is performed in South San Francisco, California. The order covers single-cell DNA and protein sequencing reagent kits supporting biomedical research. Ultimate completion is November 30, 2018. The procurement was issued under a special notice without a small business set-aside.</p>

This is a $67,980 firm fixed price purchase order awarded by the National Heart, Lung and Blood Institute (NHLBI) to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing instruments and services. The contract is for a project titled &quot;Clonal Evolution of Driver Mutations in Patients&quot; and has an ultimate completion date of September 9, 2025. The award does not have a set-aside designation. Mission Bio, a company registered in the System for Award...

Mission Bio, Inc. has been awarded a firm fixed price purchase order valued at one hundred sixty-six thousand seven hundred twenty-nine dollars by the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH). The contract is for a project titled &quot;Clonal Evolution of Driver Mutations&quot; to be performed in South San Francisco, California over a one year period concluding in August 2024. As part of the NIH's efforts to advance understanding of the...

<p>The National Heart Lung and Blood Institute awarded a purchase order to 10X Genomics, Inc. for $43,337.50 for single-cell RNA-seq technology on February 10, 2021, with a total small business set-aside designation and performance completion by March 12, 2021. Work is performed in Pleasanton, California. The order is for firm fixed price supply of single-cell genomic analysis platforms, reagents, and related consumables supporting biomedical research.</p>

The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $34,966 firm fixed-price purchase order to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services. The contract is for the delivery of Tapestri Single-Cell DNA + Protein Reagent Kits to support NHLBI's biomedical research and genomics efforts. The contract has a performance period through December 19, 2025 and does not utilize any...

<p>The National Human Genome Research Institute awarded a purchase order to Mission Bio, Inc. valued at $20,800 on August 5, 2019. Work is performed in South San Francisco, California. The order is for single-cell genomics reagents and sequencing supplies, with firm fixed-price terms and an ultimate completion date of August 5, 2019.</p>